" "
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

13th DCVMN Conference: DCVMN Must Become Stronger

Published: Monday, November 05, 2012
Last Updated: Monday, November 05, 2012
Bookmark and Share
Through establishing greater cooperation throughout the developing world on vaccine research and development.

The Developing Countries Vaccine Manufacturers Network (DCVMN) can become stronger, especially in establishing cooperation on vaccine research and development.

"DCVMN can be stronger. We have to increase vaccine availability and to improve the quality of vaccine production in developing countries," said out-going DCVMN President Akira Homma at the closing ceremony of 13th DCVMN Annual General Meeting in Kuta Bali.

Homma said DCVMN countries have committed to increasing their efforts to develop vaccines to prevent millions of deaths caused by infectious disease.

Therefore the network members must share the technology and know-how to develop the capacity to produce over 40 vaccine types that would contribute to preventing 2,5 million deaths each year, as estimated by WHO.

Homma also said that Bio Farma is an example of a successful vaccine maker in the developing world not only for being able to produce various types vaccines prequalified by the WHO, but for its initiatives and cooperation on vaccine research with many developing countries as well.

Homma, of Brazil's Bio-Manguinhos-Fiocruz vaccine manufacturer, pointed out the leading role Bio Farma had taken up in 1999 when WHO sponsored steps for the developing countries to jointly develop their capabilities in vaccine research and making.

Homma added that the largest amount of vaccines bought by WHO are produced in the developing countries as they are of the same high quality as those produced in the industrialized world, with lower prices.

The newly-elected president of the DCVMN, Mahendra Suhardono of Bio Farma, expressed his optimism that the organization could be better and become stronger, especially under his leadership for the next two years.

"We commit to increasing cooperation and technology transfer in order to increase vaccine production among developing countries in large quantities and at affordable prices. We don't only want to be sustainable, but we commit to delivering vaccines to more people as well," said Mahendra Suhardono.

Mahendra also stated that Bio Farma has offered cooperation to other developing countries. Two countries which have developed cooperation with Bio Farma are India and South Africa. So far Bio Farma has produced eleven types of vaccine, all WHO pre-qualified.

According to Mahendra, Indonesia has already achieved a "sound, technological platform" in vaccine production and therefore looks forward to establishing cooperation in vaccine research and developments with other DCVMN member countries.

The 13th DCVMN Annual General Meeting in Kuta Bali was attended by more than 100 vaccine experts and high ranking health officials from DCVMN member states and other countries as well as UN bodies.

The meeting also feature presentations and discussions from vaccine experts and government officials from the United States, Europe, Latin America and U.N. bodies.

The 14th DCVMN Annual General Meeting will be held next year in Vietnam.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,900+ scientific posters on ePosters
  • More Than 4,200+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Microdroplet Reactors Mimic Living Systems
Researchers use microdroplets to study non-equilibrium reactions like those in living organisms.
NIH Researchers Identify Striking Genomic Signature for Cancer
Institute has identified striking signature shared by five types of cancer.
CRI Develops Innovative Approach for Identifying Lung Cancer
Institute has developed innovative approach for identifying processes that fuel tumor growth in lung cancer patients.
Envigo Rat Models Proven to be Susceptible to Intra-Vaginal HSV-2 Infection and Protectable
Scientific findings establish the effectiveness of new approach to investigate the protective effects of vaccine candidates and anti-viral microbodies and to study asymptomatic primary genital HSV-2 infection.
Food Triggers Creation of Regulatory T Cells
IBS researchers document how normal diet establishes immune tolerance conditions in the small intestine.
Light Signals from Living Cells
Fluorescent protein markers delivered under high pressure.
Counting Cancer-busting Oxygen Molecules
Researchers from the Centre for Nanoscale BioPhotonics (CNBP), an Australian Research Centre of Excellence, have shown that nanoparticles used in combination with X-rays, are a viable method for killing cancer cells deep within the living body.
Therapeutic Approach Gives Hope for Multiple Myeloma
A new therapeutic approach tested by a team from Maisonneuve-Rosemont Hospital (CIUSSS-EST, Montreal) and the University of Montreal gives promising results for the treatment of multiple myeloma, a cancer of the bone marrow currently considered incurable with conventional chemotherapy and for which the average life expectancy is about 6 or 7 years.
Cellular 'Relief Valve'
A team led by scientists at The Scripps Research Institute (TSRI) has solved a long-standing mystery in cell biology by showing essentially how a key “relief-valve” in cells does its job.
Genomic Signature Shared by Five Types of Cancer
National Institutes of Health researchers have identified a striking signature in tumor DNA that occurs in five different types of cancer.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!